1. Home
  2. HOMB vs LNTH Comparison

HOMB vs LNTH Comparison

Compare HOMB & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Home BancShares Inc.

HOMB

Home BancShares Inc.

N/A

Current Price

$30.00

Market Cap

5.7B

Sector

Finance

ML Signal

N/A

Logo Lantheus Holdings Inc.

LNTH

Lantheus Holdings Inc.

N/A

Current Price

$101.63

Market Cap

6.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HOMB
LNTH
Founded
1998
1956
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.7B
6.5B
IPO Year
2006
2014

Fundamental Metrics

Financial Performance
Metric
HOMB
LNTH
Price
$30.00
$101.63
Analyst Decision
Buy
Hold
Analyst Count
10
9
Target Price
$32.88
★ $105.99
AVG Volume (30 Days)
★ 1.7M
1.0M
Earning Date
10-14-2026
11-05-2026
Dividend Yield
★ 3.07%
N/A
EPS Growth
★ 19.90
N/A
EPS
1.84
★ 3.21
Revenue
N/A
★ $343,374,000.00
Revenue This Year
$4.28
$0.40
Revenue Next Year
$3.19
$8.23
P/E Ratio
★ $16.29
$31.52
Revenue Growth
N/A
★ 3.62
52 Week Low
$25.50
$51.80
52 Week High
$31.70
$111.86

Technical Indicators

Market Signals
Indicator
HOMB
LNTH
Relative Strength Index (RSI) 53.05 63.61
Support Level $29.70 $99.84
Resistance Level $30.49 $102.66
Average True Range (ATR) 0.56 0.48
MACD -0.02 0.13
Stochastic Oscillator 31.52 92.08

Price Performance

Historical Comparison
HOMB
LNTH

About HOMB Home BancShares Inc.

Home BancShares Inc is a bank holding company that operates through its wholly owned community bank subsidiary, Centennial Bank. The bank provides a broad range of commercial and retail banking, as well as related financial services, to a diverse customer base. Its customer base includes businesses, real estate developers and investors, individuals, and municipalities. The company's loan portfolio, while diversified, is typically between half and two thirds in commercial real estate loans. The company's plan emphasizes growth, both through strategic acquisitions and organically within its existing markets. The company has one reportable segment: The Banking Segment.

About LNTH Lantheus Holdings Inc.

Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.

Share on Social Networks: